Related references
Note: Only part of the references are listed.The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I
Francesca Bufalieri et al.
CANCERS (2020)
MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway
Shujun Jiang et al.
EXPERIMENTAL CELL RESEARCH (2020)
Breast Cancer Treatment
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer
Xin-Ge Zhao et al.
CELL DEATH & DISEASE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer A Phase 1b Clinical Trial
Dejan Juric et al.
JAMA ONCOLOGY (2019)
BRCA1/2 testing: therapeutic implications for breast cancer management
Nadine M. Tung et al.
BRITISH JOURNAL OF CANCER (2018)
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation
Yunhai Li et al.
CANCER LETTERS (2018)
Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway
Ramon Garcia-Escudero et al.
ORAL ONCOLOGY (2018)
PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer
Anthony Adimonye et al.
PLOS ONE (2018)
PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis
Hongwei Fan et al.
THORACIC CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Association between telomere length and PIK3CA amplification in gastric cancer
Yu-Ran Heo et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Revisiting the Role of Bevacizumab in the Treatment of Breast Cancer
Leticia Varella et al.
SEMINARS IN ONCOLOGY (2017)
MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer
Zhao Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Breast cancer in the 21st century: from early detection to new therapies
J. A. Merino Bonilla et al.
RADIOLOGIA (2017)
Breast cancer statistics, 2017, racial disparity in mortality by state
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer
Ki Sun Jung et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women
Lorenzo Rossi et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Radiotherapy for breast cancer: The predictable consequences of an unmet need
Danielle Rodin et al.
BREAST (2016)
Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer
Yuan Tang et al.
CLINICAL BREAST CANCER (2016)
Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies
Vivek Asati et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Clinical Diagnosis and Management of Breast Cancer
Elizabeth S. McDonald et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling
L. Du et al.
ONCOGENE (2016)
Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
A. C. V. Krepischi et al.
MOLECULAR CYTOGENETICS (2016)
Advances in the surgical treatment of breast cancer
Lei Xing et al.
CHINESE CLINICAL ONCOLOGY (2016)
An Update in Breast Cancer Screening and Management
Sanjay Warrier et al.
WOMENS HEALTH (2016)
CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness
Bruno Pereira et al.
NUCLEIC ACIDS RESEARCH (2013)
Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells
Hong Jiang et al.
MOLECULAR MEDICINE REPORTS (2012)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
J. L. Dean et al.
ONCOGENE (2010)
Structure and function of KH domains
Roberto Valverde et al.
FEBS JOURNAL (2008)
Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies
Karine Buchet-Poyau et al.
NUCLEIC ACIDS RESEARCH (2007)
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Y Samuels et al.
CANCER CELL (2005)
Somatic mutation and gain of copy number of PIK3CA in human breast cancer
GJ Wu et al.
BREAST CANCER RESEARCH (2005)
Share Paper
